Physician profile
Sai K Devarapalli
NPI 1548234966
$15,037.55
in general payments reported to CMS, 2019-2025
40 companies · $1,166 in 2025
The $1,166 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $1,371 · 2021: $2,649 · 2022: $3,157 · 2023: $1,334 · 2024: $3,238 · 2025: $1,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,254 · Travel and Lodging: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,254.13 |
| Travel and Lodging | $1,484.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,685.93 | 2021-2024 | Indigo System |
| Boston Scientific Corporation | $2,470.01 | 2019-2024 | Avvigo Guidance System, Watchman Flx |
| Medtronic, INC. | $1,398.71 | 2022-2025 | Venaseal, Hawkone |
| Inari Medical, INC. | $1,242.44 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $1,007.89 | 2019-2022 | |
| Abbott Laboratories | $876.63 | 2019-2025 | Cardiomems |
| Abiomed | $799.05 | 2020-2025 | Impella |
| Amgen INC. | $494.85 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $493.06 | 2019-2025 | Igt Devices Undivided |
| Heartflow, INC. | $463.50 | 2022-2025 | Ffrct |
| Terumo Medical Corporation | $387.69 | 2019-2025 | Glidewire, Azur Cx Detachable |
| Janssen Pharmaceuticals, INC | $296.40 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $263.89 | 2019-2023 | Farxiga |
| Thrombolex, INC. | $212.14 | 2025 | Bashir Endovascular Catheter |
| Novartis Pharmaceuticals Corporation | $204.82 | 2019-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $192.67 | 2019-2025 | |
| Shockwave Medical, INC | $188.06 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $126.75 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.44 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $114.85 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $111.57 | 2022 | |
| Stryker Corporation | $100.23 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Merck Sharp & Dohme LLC | $98.18 | 2023-2025 | Verquvo |
| Chiesi USA, INC. | $86.15 | 2019-2023 | Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.82 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $58.05 | 2020 | |
| Alnylam Pharmaceuticals INC. | $55.44 | 2024 | Onpattro |
| W. L. Gore & Associates, INC. | $55.12 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Ekos Corporation | $53.42 | 2019 | |
| Cleerly, INC. | $48.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $41.55 | 2023-2025 | Wegovy, Ozempic |
| Cook Medical LLC | $38.11 | 2021 | |
| Elutia, INC. | $34.01 | 2022-2024 | Ecm Patch,Pouch |
| Scpharmaceuticals INC. | $30.49 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $29.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.58 | 2019-2024 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $24.07 | 2025 | |
| Amarin Pharma, INC. | $18.93 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.23 | 2019 | |
| Biotronik INC. | $13.49 | 2024 | Pk Papyrus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sai Devarapalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.